Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection.
During evolution, herpesviruses have developed numerous, and often very ingenious, strategies to counteract efficient host immunity. Specifically, Kaposi's sarcoma-associated herpesvirus (KSHV) eludes host immunity by undergoing a dormant stage, called latency wherein it expresses a minimal num...
Guardado en:
Autores principales: | Myung-Shin Lee, Tiffany Jones, Dae-Yong Song, Jae-Hyuk Jang, Jae U Jung, Shou-Jiang Gao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9409285dd6ca4616a8372148371e2742 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Human Mesenchymal Stem Cells of Diverse Origins Support Persistent Infection with Kaposi’s Sarcoma-Associated Herpesvirus and Manifest Distinct Angiogenic, Invasive, and Transforming Phenotypes
por: Myung-Shin Lee, et al.
Publicado: (2016) -
The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes.
por: Thomas Günther, et al.
Publicado: (2010) -
Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi’s Sarcoma-Associated Herpesvirus Latent and Lytic Replications
por: Marion Gruffaz, et al.
Publicado: (2018) -
Human Herpesvirus 8 Induces Polyfunctional B Lymphocytes That Drive Kaposi’s Sarcoma
por: Emilee R. Knowlton, et al.
Publicado: (2014) -
Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis.
por: Guillaume Suffert, et al.
Publicado: (2011)